The European Medicines Agency backed the use of Novo Nordisk's popular drug Wegovy to help ease heart failure in people with ...
The European Medicines Agency also said that extra doses of the Moderna and Pfizer-BioNTech vaccines could be given to people with underlying health conditions as early as 28 days after a second ...
An advisory committee has recommended approval in the European Union of marstacimab for severe hemophilia A or B patients without inhibitors.
The European Medicines Agency approved Afqlir and Opuviz to treat age-related macular degeneration while reiterating its ...
Greater collaboration between industry, government, policymakers and the NHS will be critical for treatment options in the UK ...
DPA International on MSN6d
EU extends authorization of the mpox vaccine to adolescentsThe European Commission on Friday extended the authorization of the Imvanex mpox vaccine to teenagers aged 12 to 17.
Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of Novo Nordisk A/S’ (NYSE ...
The latest health news covers the European Medicines Agency's approval of Novo Nordisk's Wegovy for heart conditions linked ...
Bowers added that to increase access to the latest drugs, the "cancer system" must be organized in such a way as to ...
HANSIZHUANG ® (serplulimab) was the first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback